Bliss GVS Pharma Limited (BLISSGVS) — Corporate Action | 11 August 2026

11 August 2026 · NSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

ESOP Allotment Committee approved 31,250 shares under 2019 Employee Stock Option Plan

🔄 What Changed

Issued share capital rose from 10,62,43,973 to 10,62,75,222 shares, increasing paid-up capital to Rs. 10,62,75,222

💡 Investor Takeaway

The share issuance dilutes existing shareholders' ownership through new ESOP allocations.

Bliss GVS Pharma announced on August 11, 2026 that its ESOP Allotment Committee approved the allotment of 31,250 equity shares of Re. 1 each to eligible employees who exercised stock options under the 2019 Employee Stock Option Plan. This increased the issued and subscribed share capital from 10,62,43,973 to 10,62,75,222 shares, raising the total paid-up capital to Rs. 10,62,75,222. The shares are subject to a six-month lock-in ending February 10, 2027 and rank pari passu with existing shares.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BLISSGVS ✨ Ask AI About This

About Bliss GVS Pharma Limited (BLISSGVS)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹7,530.52 CrP/E: 55.1ROE: 11.4%ROCE: 17.5%Div Yield: 0.14%

View full BLISSGVS stock details →

📡 Get AI alerts when BLISSGVS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BLISSGVS — Free

💡 Ask AI about this filing

"How will this ESOP issuance affect Bliss GVS Pharma's EPS and share price?""What is the current market price of Bliss GVS Pharma shares post-announcement?""How does this ESOP compare to previous employee stock option plans in terms of dilution?"

Ask AI Free →

📊 More BLISSGVS filings

Announcement — 29 September 2026Bliss GVS Pharma announced that its trading window closes on October 1, 2026, ahead of unaudited qua...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced on September 28, 2026 that Anupam Rasayan India Limited, via its subsidia...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced a board meeting on October 1, 2026, to consider establishing two employee...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced the completion of Anupam Rasayan India's acquisition of 47.95% stake, mak...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced that its board approved the reclassification of 22 outgoing promoters fro...

See all BLISSGVS filings →

🔥 Also filed on 11 August 2026

ULTRACEMCOUltraTech Cement LimitedAnnouncement SUDEEPPHRMSudeep Pharma LimitedFinancial Results SUTLEJTEXSutlej Textiles and Industries LimitedFinancial Results RBZJEWELRBZ Jewellers LimitedFinancial Results TATVATatva Chintan Pharma Chem LimitedCorporate Action AETHERAether Industries LimitedCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BLISSGVS files new disclosures

Track BLISSGVS filings, board meetings, and corporate actions. Free email alerts at 5 PM.